Skip to content

Novartis announces full takeover plans of Alcon

Novartis has proposed a full purchase of Alcon, Inc (ALC:NYSE) for a reported $39.3 billion bringing the total cash price of its Alcon acquisition to just under $50 billion (Novartis had previously bought a 25% stake in the company in April 2008 for $10.4 billion).